{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:16:23Z","timestamp":1769148983732,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GI0301"],"award-info":[{"award-number":["01GI0301"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["QLG3-CT-2002-81606"],"award-info":[{"award-number":["QLG3-CT-2002-81606"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.neurobiolaging.2007.07.014","type":"journal-article","created":{"date-parts":[[2007,9,6]],"date-time":"2007-09-06T16:07:38Z","timestamp":1189094858000},"page":"615-621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Increased frequency of positive family history of dementia in sporadic CJD"],"prefix":"10.1016","volume":"30","author":[{"given":"Anna","family":"Krasnianski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"von Ahsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uta","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter J.","family":"Schulz-Schaeffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans A.","family":"Kretzschmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor W.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib1","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(99)01342-2","article-title":"Codon 129 prion protein genotype and sporadic Creutzfeldt\u2013Jakob disease","volume":"353","author":"Alp\u00e9rovitch","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib2","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0140-6736(94)90691-2","article-title":"The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt\u2013Jakob disease. The French Research Group on Epidemiology of Human spongiform encephalopathies","volume":"344","author":"Amouyel","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000095246","article-title":"Apolipoprotein E epsilon4 allele is associated with vascular dementia","volume":"22","author":"Baum","year":"2006","journal-title":"Dement. Geriatr. Cog. Disord."},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib4","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1212\/WNL.51.3.734","article-title":"Polymorphism of the prion protein is associated with cognitive impairment in the elderly: the EVA study","volume":"51","author":"Berr","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000092960","article-title":"Apolipoprotein E epsilon4 allele frequency in vascular dementia","volume":"22","author":"Davidson","year":"2006","journal-title":"Dement. Geriat. Cog. Disord."},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2005.05.025","article-title":"Is M129V of PRNP gene associated with Alzheimer's disease? A case\u2013control study and a meta-analysis","volume":"27","author":"Del Bo","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ana.10507","article-title":"PRNP Val129 homozygosity increases risk for early-onset Alzheimer's disease","volume":"53","author":"Dermaut","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib9","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1212\/01.wnl.0000192102.41141.9e","article-title":"Apolipoprotein E and Alzheimer's disease","volume":"66","author":"Huang","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib10","first-page":"1285","article-title":"Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt\u2013Jakob disease","volume":"140","author":"Kitamoto","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","article-title":"Genetic prion disease: the EUROCJD experience","volume":"118","author":"Kovacs","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib12","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.1996.00550090125018","article-title":"Diagnostic criteria for sporadic Creutzfeldt\u2013Jakob disease","volume":"53","author":"Kretzschmar","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib13","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000160117.56690.B2","article-title":"Mortality from Creutzfeldt\u2013Jakob disease and related disorders in Europe, Australia, and Canada","volume":"64","author":"Ladogana","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/sim.4780040211","article-title":"Comparative analysis of two rates","volume":"4","author":"Miettinen","year":"1985","journal-title":"Stat. Med."},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000083178","article-title":"Tau protein, Abeta 42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies","volume":"19","author":"Mollenhauer","year":"2005","journal-title":"Dement. Geriat. Cog. Disord."},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0304-3940(95)11366-5","article-title":"Allelic variation of apolipoprotein E in Japanese sporadic Creutzfeldt\u2013Jakob disease patients","volume":"187","author":"Nakagawa","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib17","series-title":"Dementia","author":"O\u2019Brien","year":"2000"},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/352340a0","article-title":"Homozygous prion protein genotype predisposes to sporadic Creutzfeldt\u2013Jakob disease","volume":"352","author":"Palmer","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/oxfordjournals.jhered.a111573","article-title":"Population genetics software for exact tests and ecumenicism","volume":"86","author":"Raymond","year":"1995","journal-title":"J. Heredity"},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib20","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/jnnp.72.5.639","article-title":"Apolipoprotein E polymorphism in German patients with frontotemporal degeneration","volume":"72","author":"Riemenschneider","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0304-3940(95)12030-8","article-title":"Apolipoprotein E in sporadic and familial Creutzfeldt\u2013Jakob disease","volume":"199","author":"Salvatore","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib22","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/0140-6736(93)91709-U","article-title":"Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases","volume":"342","author":"Saunders","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0002-9440(10)64705-0","article-title":"The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases","volume":"156","author":"Schulz-Schaeffer","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(97)09468-3","article-title":"Case-control study of risk factors of Creutzfeldt\u2013Jakob disease in Europe during 1993\u201395","volume":"351","author":"van Duijn","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3233\/JAD-1999-1606","article-title":"Decreased levels of amyloid-beta 1\u201342 in cerebrospinal fluid of Creutzfeldt\u2013Jakob disease patients","volume":"1","author":"Van Everbroeck","year":"1999","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib26","first-page":"361","article-title":"Human transmissible spongiform encephalopathies","volume":"47","author":"WHO","year":"1998","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s004390050204","article-title":"Genetic basis of Creutzfeldt\u2013Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene","volume":"98","author":"Windl","year":"1996","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib28","first-page":"11","article-title":"Human apolipoprotein E isoprotein subclasses are genetically determined","volume":"33","author":"Zannis","year":"1981","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib29","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archneur.1996.00550120041014","article-title":"Apolipoprotein E phenotype frequency and cerebrospinal fluid concentration are not associated with Creutzfeldt\u2013Jakob disease","volume":"53","author":"Zerr","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2007.07.014_bib30","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.55.6.811","article-title":"Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt\u2013Jakob disease","volume":"55","author":"Zerr","year":"2000","journal-title":"Neurology"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458007002989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458007002989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:58:19Z","timestamp":1762264699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458007002989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0197458007002989"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.07.014","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased frequency of positive family history of dementia in sporadic CJD","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}